GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.75
+0.05 (0.28%)
At close: Feb 11, 2026

TPE:3164 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,5271,7482,1372,0472,1031,925
Market Cap Growth
-9.27%-18.22%4.39%-2.67%9.23%-13.05%
Enterprise Value
1,4301,7062,0221,8181,9371,653
Last Close Price
17.7519.4823.3421.7821.4019.02
PE Ratio
45.5230.5264.7735.9318.5931.62
PS Ratio
3.904.546.725.554.925.92
PB Ratio
1.101.181.481.371.381.30
P/TBV Ratio
1.201.301.631.521.531.45
P/FCF Ratio
17.0621.871655.1831.11--
P/OCF Ratio
16.1714.1061.7614.9418.8416.28
EV/Sales Ratio
3.654.436.364.934.535.08
EV/EBITDA Ratio
12.8515.7729.3916.5413.5418.62
EV/EBIT Ratio
32.5341.98289.2929.3415.4923.29
EV/FCF Ratio
15.9821.351565.8627.64--
Debt / Equity Ratio
0.080.080.040.020.020.02
Debt / EBITDA Ratio
0.951.060.810.310.220.37
Debt / FCF Ratio
1.191.4945.160.53--
Net Debt / Equity Ratio
-0.15-0.16-0.19-0.24-0.25-0.29
Net Debt / EBITDA Ratio
-1.97-2.22-3.93-3.33-2.72-4.85
Net Debt / FCF Ratio
-2.37-3.00-209.14-5.5773.6321.02
Asset Turnover
0.240.230.190.220.260.20
Inventory Turnover
1.881.781.492.423.583.31
Quick Ratio
3.472.802.522.823.435.39
Current Ratio
4.823.873.183.244.176.28
Return on Equity (ROE)
1.77%3.26%1.52%3.14%7.29%4.11%
Return on Assets (ROA)
1.69%1.51%0.26%2.28%4.72%2.79%
Return on Invested Capital (ROIC)
2.67%2.48%0.48%3.92%8.99%5.55%
Return on Capital Employed (ROCE)
3.00%2.60%0.50%4.00%8.00%4.70%
Earnings Yield
2.26%3.28%1.54%2.78%5.38%3.16%
FCF Yield
5.86%4.57%0.06%3.21%-0.25%-1.06%
Dividend Yield
4.52%4.11%2.14%3.21%5.14%3.68%
Payout Ratio
200.65%75.56%183.26%166.75%53.42%116.86%
Buyback Yield / Dilution
0.09%-0.18%0.10%0.09%1.50%1.34%
Total Shareholder Return
4.57%3.93%2.25%3.31%6.64%5.02%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.